KantarHealth expands China team

KantarHealth continues to expand its leadership team in China, naming Hettie Han director of healthcare research in its Beijing office. Han will be responsible for providing research programmes and consulting guidance to help pharmaceutical and biotech clients optimise their business results in the Chinese market, anticipated to be the largest in the world by 2050.

Scott Davies, general manager of KantarHealth China said: "Hettie is a powerful addition to our senior team with more than a decade of pharmaceutical research experience, including deep expertise in the critical oncology category. Having spent her career working in pharmaceutical companies, she has firsthand insight into our customers' needs and challenges so can truly partner with them to drive their growth in the Chinese market."

Han commented: "I am excited by KantarHealth's commitment to supporting its clients' success – locally and around the world. Its focus on providing evidence-based decision support; its broad global footprint; its worldwide communities of business and therapeutics experts; and its unparalleled range of competencies, ensure I can always bring my customers the best solutions and best support team to maximise their performance."

Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, KantarHealth is the world's leading healthcare-focused global consultancy, speicliasing in portfolio optimisation, market access, safety and outcomes and brand and customer insights.

KantarHealth continues to expand its leadership team in China, naming Hettie Han director of healthcare research in its Beijing office. Han will be responsible for providing research programmes and consulting guidance to help pharmaceutical and biotech clients optimise their business results in the Chinese market, anticipated to be the largest in the world by 2050.

Scott Davies, general manager of KantarHealth China said: "Hettie is a powerful addition to our senior team with more than a decade of pharmaceutical research experience, including deep expertise in the critical oncology category. Having spent her career working in pharmaceutical companies, she has firsthand insight into our customers' needs and challenges so can truly partner with them to drive their growth in the Chinese market."

Han commented: "I am excited by KantarHealth's commitment to supporting its clients' success – locally and around the world. Its focus on providing evidence-based decision support; its broad global footprint; its worldwide communities of business and therapeutics experts; and its unparalleled range of competencies, ensure I can always bring my customers the best solutions and best support team to maximise their performance."

Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, KantarHealth is the world's leading healthcare-focused global consultancy, speicliasing in portfolio optimisation, market access, safety and outcomes and brand and customer insights.